Drug profile · INN
ethacrynate sodium
ETHACRYNATE SODIUM
ethacrynate sodium (ETHACRYNATE SODIUM) is a sodium-(potassium)-chloride cotransporter 2 inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — ethacrynate sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ethacrynate sodium (ETHACRYNATE SODIUM) is a sodium-(potassium)-chloride cotransporter 2 inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium-(potassium)-chloride cotransporter 2 inhibitor
Primary target: Solute carrier family 12 member 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ethacrynate sodium?
ethacrynate sodium (ETHACRYNATE SODIUM) is a sodium-(potassium)-chloride cotransporter 2 inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ethacrynate sodium?
ETHACRYNATE SODIUM is a marketed brand name for ethacrynate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ethacrynate sodium?
ethacrynate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.